Evidence map›Paper›PMID 41587484›Full record

ArticleBlood advances2026

Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant patients with MPN.

Tsewang Tashi, Lee-Yung Shih, Yi-Te Yo, Amy E Sullivan, Ho-Yen Chueh, Ming-Chung Kuo, Amanda Smith, Soo-Jin Kim, Brynn Parsegov, Brandi N Reeves and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tsewang TashiDivision of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.ORCID 0000-0002-2785-866X
Lee-Yung ShihDivision of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.ORCID 0000-0003-1866-7922
Yi-Te YoPharmaEssentia Corporation, Taipei, Taiwan.ORCID 0009-0003-9676-1524
Amy E SullivanDepartment of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT.
Ho-Yen ChuehDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.ORCID 0009-0005-9223-6727
Ming-Chung KuoDivision of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
Amanda SmithDivision of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.ORCID 0009-0002-5484-2927
Soo-Jin KimDivision of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.
Brynn ParsegovDivision of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.ORCID 0009-0005-2226-0561
Brandi N ReevesLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.ORCID 0000-0002-2106-3698
Jihyun SongDivision of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.ORCID 0000-0002-1269-0892
Josef T PrchalDivision of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.ORCID 0000-0002-8019-2940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41587484
PMCPMC13049638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.